Capital Change Notice - Grant of Options

Capital Change Notice

Updated as at February 2025

Notice of grant of Options under the Oceania Healthcare Share Option Plan
This notice is given under the NZX Listing Rule 3.13.1 and relates to the grant of options
(Options) to acquire ordinary shares in Oceania Healthcare Limited under the Oceania
Healthcare Share Option Plan.

Section 1: Issuer information
Name of issuer Oceania Healthcare Limited
NZX ticker code OCA
Class of financial product Options to acquire ordinary shares
ISIN (If unknown, check on NZX website) NZOCAE0002S0
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 12,967,733 Options
Nominal value (if any) N/A
Issue/acquisition/redemption price per security N/A
Nature of the payment (for example, cash or
other consideration)
No consideration is payable for the issue of
Options, in accordance with the Oceania
Healthcare Share Option Plan Rules.
Amount paid up (if not in full) N/A
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

70.5777 % of all Options currently on issue
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the
Financial Product in relation to other Classes of
Financial Product) or the Option (for example,
the exercise price and exercise date)
Subject to continued employment, Option
holders will be able to exercise the Options
during the exercise period, which begins 10
Business Days after announcement of OCA’s
final FY29 results in 2029 (Vesting Date) and
ends 90 days after the Vesting Date.
The exercise price for the Options is $0.75
cents, being the volume weighted average
price of OCA shares on the NZX Main Board
for the five trading day period commencing
two trading days after announcement of
OCA’s FY26 results (i.e. five day volume
weighted average price from 26 May 2026).
On exercise of the Options, OCA will facilitate
a cashless (net settled) exercise by issuing
such number of shares as is equal to the
difference between the then current market
value and the exercise price, multiplied by the
number of Options being exercised, divided
by the then current market value.

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

OCA will pay tax on the Option holder’s
behalf for the taxable benefit received by the
holder under the plan.

Reason for issue/acquisition/redemption and
specific authority for
issue/acquisition/redemption/ (the reason for
change must be identified here)
The board of OCA has resolved to offer the
Options to selected employees in order to: (a)
reward and retain participants; (b) drive
longer-term performance and alignment of
incentives of the participants with the
interests of Oceania’s shareholders; and (c)
encourage longer term decision-making by
the participants.
Total number of Financial Products of the Class
after the
issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number
of Financial Products of the Class held as
Treasury Stock after the
issue/acquisition/redemption.
Total number of Options on issue as at the
date of this notice after the issue disclosed in
this notice: 31,341,429
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
Board resolutions 9 June 2026 and NZX
Listing Rule 4.6.1
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
Options are subject to the Oceania
Healthcare Share Option Plan Rules. New
ordinary shares issued upon exercise of the
Options will rank equally in all respects with
the ordinary shares already on issue.
Date of issue/acquisition/redemption
2
10 June 2026
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Sarah Miller
Contact person for this announcement Sarah Miller
Contact phone number +64 21 937 857
Contact email address company.secretary@oceaniahealthcare.co.nz
Date of release through MAP

10 June 2026




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).